How to Cite
Abstract
The new technology of combined treatment for patients with ovarian carcinoma of III-IV stages and its relapse is presented. The essentially new component is systemic radiotherapy in nontumoricidal doses. It is used with both traditional surgical and chemotherapeutic components. Systemic radiotherapy is carried out in a form of subtotal body irradiation in two dosetime options with total dose of 1 Gy and 9 Gy. The choice of radiation option is carried out taking into account the initial somatic resource of patients estimated by the condition of lymphopoiesis. The use of systemic radiotherapy in combined treatment of advanced ovarian carcinoma allowed to achieve the significant increase of 3-, 5-year survival in patients as compared to traditional chemosurgical method. Indirect mechanism of nontumoricidal systemic radiotherapy is to be considered as a vital way for tumor control.References
Бабаева А.Г. Регенерация и система иммуногенеза. — М.: Медицина. — 1985. — 256 с.
Винокуров В.Л. Рак яичников: закономерности метастазирования и выбор адекватного лечения больных. - СПб: Из-во ФОЛИАНТ. — 2004. — 336 с.
Гранов А.М., Шутко А.Н. Парадоксы злокачественного роста и тканевой несовместимости. — СПб: Гиппократ. — 2002. — 223 с.
Рябов С. И., Ракитянская И.А., Шутко А.Н. и др. Концепция морфообразовательной функции лимфоцитов и ее значение для практики // Проблема адаптации биологических систем к экстремальным факторам. — М.: Наука. — 1991. — С. 620-665.
Тюляндин С. А. Рак яичников: химиотерапия второй линии // Практ. онкол. — 2000. — № 4. — С. 32-37.
Урманчеева А.Ф., Кутушева Г.Ф., Ульрих Е.А. Опухоли яичника (клиника, диагностика и лечение). — СПб.: Изд-во Н-Л. — 2012. — 68 с.
Hur J., Yang H.-M., Yoon Ch.-H. et al. Identification of a novel role of T cells in postnatal vasculogenesis. Characterization of endothelial progenitor cell colonies // Circulation. — 2007. — Vol. 116. — P. 1671-1682.
Shoutko А., Shatinina N., Chronic cancer — could it’s be? «Coherence» // Int. J. Iintegrative Med. — 1998. — Vol. 2. — P. 36-40.
Shoutko A., Ekimova L., Vasilyeva M., Shatinina N., Tissue factors involved in cancer induction. — In: Peter J., Schnider G., Bayer A. (eds). High level of natural radiation and radon areas: radiation dose and health effects. Bundesamt fur Strahlenscutz Schriften. — Munich, Germany, 2000. — Vol. 2. — P. 467-470.
Shoutko А., Yurkova. Indirect control of tumor growth inradiotherapy «Coherence» // Int. J.Integrative Med. — 2001. — Vol. 2. — P. 36-40.
Shoutko A., Lytkina I., Ekimova L. et al. Regular longterm fluctuations of death rate and lymphopoiesis by tumor patients treated with different cytotoxic agents // 32nd Annual Meeting of the Europ. Society for Radiation Biology (ESRB). — Belgium. — 2002. — P. 141-142.
Shutko A., Ekimova L., Shoumski I. et al. Limphopoiesis of treated oncological patients is a probable source of individual life span’s variability // 13th Int. Congress of Radiat. Res. (ICRR). — San Francisco, CA, USA. — 08.12.2007. — P. 58.
Shoutko A., Ekimova L., Mus V., Sokurenko V. Fluctuations of CD34+cells number in blood of cancer patients during final year of life // Medical Health Science J. — 2012. — Vol. 13. — P. 7-13.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...